Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 68001-523

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 68001-523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Fosaprepinjcarton)

Packaging label for Fosaprepitant for Injection 150 mg per vial, a lyophilized powder for solution for intravenous use, labeled by BluePoint Laboratories. The label includes ingredient details, reconstitution instructions with 5 mL of 0.9% Sodium Chloride, storage conditions, manufacturer information (ASPIRO PHARMA LIMITED in India), barcodes, and caution notes about divalent cations. The package dimensions and color specifications are also noted.*

FDA Label Image

Label (Fosaprepinjlabel)

Label for Fosaprepitant injection, lyophilized powder for solution, 150 mg per vial. It is a single-dose vial for intravenous use, labeled by BluePoint Laboratories. The label includes storage instructions to refrigerate and indicates the product is sterile with no reconstitution needed. Manufacturer is Aspiro Pharma Limited India.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure diagram of Fosaprepitant dimeglumine, the active ingredient in Fosaprepitant injection powder for solution. The image shows the molecular layout including fluorine, trifluoromethyl, and hydroxy groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.